Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5569)
All Articles published online
|
Publishing Process of This Article
|
Dec 27, 2021 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xu L, Chen L, Zhang W. Neoadjuvant treatment strategies for hepatocellular carcinoma. World J Gastrointest Surg 2021; 13(12): 1550-1566 [PMID: 35070063 DOI: 10.4240/wjgs.v13.i12.1550] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i12/1550.htm |
| Number | Citing Articles |
| 1 |
Deniz Can Guven, Hasan Cagri Yildirim, Elvin Chalabiyev, Fatih Kus, Feride Yilmaz, Serkan Yasar, Arif Akyildiz, Burak Yasin Aktas, Suayib Yalcin, Omer Dizdar. Emerging treatment strategies in hepatobiliary cancer. Expert Review of Anticancer Therapy 2023; 23(3): 243 doi: 10.1080/14737140.2023.2183844
|
| 2 |
Luca Tirloni, Ilenia Bartolini, Carlo Gazia, Andrea Scarinci, Gian Luca Grazi. A contemporary view on vascular resections and reconstruction during hepatectomies. Updates in Surgery 2024; 76(5): 1643 doi: 10.1007/s13304-024-01934-z
|
| 3 |
Min Deng, Hao Cai, Benyi He, Renguo Guan, Carol Lee, Rongping Guo. Hepatic arterial infusion chemotherapy versus transarterial chemoembolization, potential conversion therapies for single huge hepatocellular carcinoma: a retrospective comparison study. International Journal of Surgery 2023; doi: 10.1097/JS9.0000000000000654
|
| 4 |
Juana V. Barrera, Leonard Dallag, Rubeel Akram, Jason Salsamendi, Camilo Barragan, Chase J. Wehrle, Jamaal Benjamin, Maria del Pilar Bayona Molano. Locoregional Therapies and Interventional Radiology in Managing Hepatocellular Carcinoma: A Comprehensive Approach to Bridging, Downstaging, and Liver Transplantation. Digestive Disease Interventions 2024; doi: 10.1055/s-0044-1791837
|
| 5 |
Jessica Elderkin, Najeeb Al Hallak, Asfar S. Azmi, Hussein Aoun, Jeffrey Critchfield, Miguel Tobon, Eliza W. Beal. Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management. Cancers 2023; 15(21): 5118 doi: 10.3390/cancers15215118
|
| 6 |
Rubén Caiña Ruiz, Enrique Toledo Martínez, Edward Joseph Anderson, Víctor Valbuena Jabares, Roberto Fernández Santiago, Federico Castillo, Juan Echeverri, Mar Achalandabaso, Francisco José González Sánchez, Emilio Fábrega, Antonio Cuadrado, José Ignacio Fortea, Javier Crespo, Juan Carlos Rodríguez Sanjuán. Effect of Bridging Therapy on Survival in Hepatocellular Carcinoma Patients Who Receive Liver Transplants. Transplantation Proceedings 2022; 54(9): 2528 doi: 10.1016/j.transproceed.2022.09.007
|
| 7 |
Shohei Yoshiya, Noboru Harada, Takeo Toshima, Katsuya Toshida, Yukiko Kosai, Takahiro Tomino, Yoshihiro Nagao, Hiroto Kayashima, Shinji Itoh, Tomoharu Yoshizumi. Treatment strategy for hepatocellular carcinoma recurrence in the transplant era: Focusing on the Japan criteria. Surgery Today 2024; 54(1): 64 doi: 10.1007/s00595-023-02710-z
|
| 8 |
Silvia Cesario, Virginia Genovesi, Francesca Salani, Enrico Vasile, Lorenzo Fornaro, Caterina Vivaldi, Gianluca Masi. Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution. Life 2023; 13(7): 1562 doi: 10.3390/life13071562
|
| 9 |
Kelly Mahuron, Gagandeep Singh. Defining a New Classification System for the Surgical Management of Neuroendocrine Tumor Liver Metastases. Journal of Clinical Medicine 2023; 12(7): 2456 doi: 10.3390/jcm12072456
|
| 10 |
Kaihua Tang, Xiaoting Li, Jianwen Mo, Yixuan Chen, Chengyu Huang, Ting Li, Tianjian Luo, Zhijian Zhong, Yongqiang Jiang, Dengfeng Yang, Weiliang Mo. CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-34261-1
|